Sailin HbS becomes Worlds First prohylactic management Remedy for Sickle Cell anemia


Posted December 10, 2019 by communicationsinc

New Delhi based SAI Phytoceuticals (P) Ltd. has become the first organisation to introduce Sailin -HbS, the World’s First Herbal Remedy for Sickle Cell anemia (SCD) in India.

 
New Delhi based SAI Phytoceuticals (P) Ltd. has become the first organisation to introduce Sailin -HbS, the World’s First Herbal Remedy for Sickle Cell anemia (SCD) in India. It has tied with Acurath Partners for the marketing, Distribution & sales of the product across India.

There are 350 million people (NCBI)having Sickle Cell anemia Worldwide. In India, 20% of children with SCD died by the age of two (ICMR surveys), and 30% of children with SCD among tribal communities die before they reach adulthood. About 90% of patients survive to age 20 and only 50% survive beyond the fifth decade. In 2001, according to one study, the estimated age of survival for sickle-cell patients was 53 years old for men and 58 years old for women with homozygous SCD

Mr. Anil Bhansali, Director Sai Phytoceuticals Private Limited, while making the announcement said “Sailin-HbS™ is a new improved chemistry and has anti sickling properties of above 90%. Sailin-HbS™ has been found very safe and a no-risk formulation so no Antidote is required”

SCD is a genetic disorder inherited from Parents' genes and is a condition in which there aren't enough healthy red blood cells to carry adequate oxygen throughout your body. The polymerization happens in the DNA and the Red blood cell becomes sickle which obstructs the flow of red blood cells to carry oxygen to various organs in the body resulting in their damage and unbearable pain.

Mr. Vishal Gaur, of Acurath Partners, said “We have seen the successful results of Sailin –HbS across Nigeria. Not only do we have a cause to give relief to patients of Sickle Cell Disease, but we also have the opportunity to introduce a very cost-effective solution, when you compare other expensive medicines or methods which have been recently announced.

India, which has the third-highest number of births with sickle cell anemia in the world after Nigeria and DR Congo, has the prevalence of the disease spread across Indian states of tribal population from Mizoram, Odissa, Andhra Pradesh, Tamil Nadu, Manipur, Jharkhand, Madhya Pradesh, Chattisgarh, Kerala, Gujarat, Telangana, West Bengal, Maharashtra & Assam.

SCD gives rise to many chronic health disorders such as stroke, infections and increases the risk of death.

A person suffering from SCD inherits two copies of the Sickle Cell gene, one from each parent. Those who inherit sickle cell gene only from one parent and a normal cell from others have a condition called Sickle Cell Trait. The clumps of sickle cells block blood flow in the vessels that lead to the limbs & organs. This causes pain, serious Infections, and Organ Damage.

Developed after dedicated research for more than 2 decades, Sailin HbS is approved by drug authorities to manufacture in India.

• Sailin-HbS™ has NO side effects on vital signs or physiological and biochemical variables. It’s 100% safe.
• The raw material used to prepare this medicine has been used for decades as per Ayurveda and Siddha.
• Sailing HbS significantly reduced the episodes of SCD associated crises and severe pain with statistical value (p
-- END ---
Share Facebook Twitter
Print Friendly and PDF DisclaimerReport Abuse
Contact Email [email protected]
Issued By Pragya Mishra
Phone 01140648814
Business Address A- 210/4, Shahpur Jat, Near Siri Fort, New Delhi, Delhi 110049
Country India
Categories Health
Tags ayurvedic , health , medicine
Last Updated December 10, 2019